|
The U.S. Food and Drug Administration has granted Cardica 510(k) clearance to market the PAS-Port® Proximal Anastomosis System for use in cardiac bypass surgery.
PAS-Port is a fully-automated, integrated device used to perform an anastomosis between a saphenous vein and the aorta during either on- or off-pump CABG surgery.
Marketed in Japan and Europe, where it has been deployed by surgeons more than 8,800 times, the PAS-Port system is now also commercially available in the United States. Click here for more information.
|
